Abstract:Even though existing chemotherapeutic agents, including paclitaxel (PTX), possess superior anticancer activity, their application is limited because of extreme hydrophobicity. Here, a dendrimer-based nanoparticles system has been prepared for improved delivery of loaded paclitaxel to the tumor. The cell-penetrating peptides, octa-arginine (R) and vitamin-E succinate (VES), had been conjugated to the PEGylated generation 4 polyamidoamine dendrimer (D) to form RVES-PD. The synthesized polymers had been characterized by 1NMR, IR, and gel permeation chromatography. The PTX-loaded RVES-PD (RVES-PD-PTX) was physicochemically characterized for particle size, zeta potential analysis, drug loading, release, and encapsulation studies. Cellular uptake, cytotoxicity, and apoptosis determination studies were carried out in human lung cancer cells (A549) in monolayers and spheroids. In vivo antitumor efficacy of RVES-PD-PTX was determined using B16F10 tumor-bearing mice. The results indicated that the RVES-PD nanoparticles were taken up by cancer cells effectively and demonstrated improved cellular translocation compared to nontargeted VES-PD. The cytotoxicity study revealed that RVES-PD-PTX exhibited the highest cytotoxicity of PTX compared to nontargeted VES-PD-PTX and free PTX in the PTX concentration range of 0-50 μg/mL. RVES-PD-PTX-induced apoptosis as analyzed by the Annexin V assay and suppressed the growth of spheroids to the highest extent compared to VES-PD-PTX and free PTX. Furthermore, the biodistribution study indicated that the RVES-PD had higher accumulation in tumor compared to VES-PD. The in vivo experiment using B16F10 tumor-bearing mice demonstrated that the RVES-PD treatment resulted in the highest rate of tumor volume reduction and apoptosis primarily by upregulating caspase 3/7 to the highest extent compared to VES-PD and free PTX. In conclusion, the developed RVES-PD could load PTX and showed efficient cell penetration and improved PTX-mediated cytotoxicity in all tested in vitro and in vivo assay systems. The results strongly suggest further exploration of this developed PTX-nanoformulation in cancer treatment.

Design, development and evaluation of Resveratrol transdermal patches for breast cancer therapy

Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells

Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation

Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation

Enhancing resveratrol pharmacokinetics and cytotoxicity in ovarian cancer cells via nanostructured lipid carriers

Thermosensitive Hydrogels Loaded with Resveratrol Nanoemulsion: Formulation Optimization by Central Composite Design and Evaluation in MCF-7 Human Breast Cancer Cell Lines

Innovative transdermal doxorubicin patches prepared using greenly synthesized iron oxide nanoparticles for breast cancer treatment

Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch

Dissolving microneedle transdermal patch loaded with Risedronate sodium and Ursolic acid bipartite nanotransfersomes to combat osteoporosis: Optimization, characterization, in vitro and ex vivo assessment

Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells

Mesoporous Silica Nanoparticles Loaded with Resveratrol Are Used for Targeted Breast Cancer Therapy

Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action

Design of a Long-Acting Rivastigmine Transdermal Delivery System: Based on Computational Simulation

Development and Validation of RP-HPLC Method for Quantification of Resveratrol in a Resveratrol-Solid Lipid Nanoparticles Loaded Microneedles Patch

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch

Novel Nanocarriers for Targeted Topical Skin Delivery of the Antioxidant Resveratrol

Pharmacodynamic Studies of Pravastatin Sodium Nanoemulsion Loaded Transdermal Patch for Treatment of Hyperlipidemia

Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises

Cell-Penetrating Peptide and α-Tocopherol-Conjugated Poly(amidoamine) Dendrimers for Improved Delivery and Anticancer Activity of Loaded Paclitaxel

Formulation, optimization and characterization of raloxifene hydrochloride loaded PLGA nanoparticles by using taguchi design for breast cancer application

Fabrication and characterization of transdermal delivery of ribociclib nanoemulgel in breast cancer treatment